• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒突变对严重急性呼吸综合征冠状病毒2特异性T细胞识别的影响。

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.

作者信息

de Silva Thushan I, Liu Guihai, Lindsey Benjamin B, Dong Danning, Moore Shona C, Hsu Nienyun Sharon, Shah Dhruv, Wellington Dannielle, Mentzer Alexander J, Angyal Adrienn, Brown Rebecca, Parker Matthew D, Ying Zixi, Yao Xuan, Turtle Lance, Dunachie Susanna, Maini Mala K, Ogg Graham, Knight Julian C, Peng Yanchun, Rowland-Jones Sarah L, Dong Tao

机构信息

The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2RX, UK.

Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, P.O. Box 273, Banjul, The Gambia.

出版信息

iScience. 2021 Nov 19;24(11):103353. doi: 10.1016/j.isci.2021.103353. Epub 2021 Oct 28.

DOI:10.1016/j.isci.2021.103353
PMID:34729465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8552693/
Abstract

We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global sequence data. Several variants within nucleocapsid and ORF3a epitopes have arisen independently in multiple lineages and result in loss of recognition by epitope-specific T cells assessed by IFN-γ and cytotoxic killing assays. Complete loss of T cell responsiveness was seen due to Q213K in the A∗01:01-restricted CD8+ ORF3a epitope FTSDYYQLY; due to P13L, P13S, and P13T in the B∗27:05-restricted CD8+ nucleocapsid epitope QRNAPRITF; and due to T362I and P365S in the A∗03:01/A∗11:01-restricted CD8+ nucleocapsid epitope KTFPPTEPK. CD8+ T cell lines unable to recognize variant epitopes have diverse T cell receptor repertoires. These data demonstrate the potential for T cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T cell as well as humoral immunity.

摘要

我们通过分析全球序列数据来识别新冠病毒主要T细胞表位中的氨基酸变体。核衣壳蛋白和ORF3a表位中的几种变体在多个谱系中独立出现,并导致通过IFN-γ和细胞毒性杀伤试验评估的表位特异性T细胞对其识别能力丧失。在A∗01:01限制性CD8+ ORF3a表位FTSDYYQLY中,Q213K导致T细胞反应性完全丧失;在B∗27:05限制性CD8+核衣壳蛋白表位QRNAPRITF中,P13L、P13S和P13T导致T细胞反应性完全丧失;在A∗03:01/A∗11:01限制性CD8+核衣壳蛋白表位KTFPPTEPK中,T362I和P365S导致T细胞反应性完全丧失。无法识别变体表位的CD8+ T细胞系具有多样的T细胞受体库。这些数据证明了T细胞逃逸的可能性,并强调需要持续监测能够逃避T细胞免疫和体液免疫的变体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/341e1473ae88/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/c89cd215fca9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/de05fe7f73f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/996b28c842e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/341e1473ae88/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/c89cd215fca9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/de05fe7f73f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/996b28c842e8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3991/8602043/341e1473ae88/gr3.jpg

相似文献

1
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.病毒突变对严重急性呼吸综合征冠状病毒2特异性T细胞识别的影响。
iScience. 2021 Nov 19;24(11):103353. doi: 10.1016/j.isci.2021.103353. Epub 2021 Oct 28.
2
Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike.在 SARS-CoV-2 不断进化的谱系中进行肽组监测,揭示了核衣壳蛋白中与棘突蛋白中最有可能导致 T 细胞表位丢失的变异体具有 HLA 结合保守性。
Front Immunol. 2022 Jun 23;13:918928. doi: 10.3389/fimmu.2022.918928. eCollection 2022.
3
In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.对新型 SARS-CoV-2 谱系中突变表位的计算机分析表明,全球 CD8+T 细胞反应性增强,同时也存在免疫逃逸迹象。
Infect Genet Evol. 2022 Apr;99:105236. doi: 10.1016/j.meegid.2022.105236. Epub 2022 Feb 8.
4
Characterizing HLA-A2-restricted CD8 T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients.鉴定新冠病毒灭活疫苗接种者中HLA-A2限制性CD8 T细胞表位及对奥密克戎变异株的免疫反应
Front Immunol. 2025 Mar 18;16:1534530. doi: 10.3389/fimmu.2025.1534530. eCollection 2025.
5
CD8 T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2.CD8 T 细胞表位变异提示 SARS-CoV-2 刺突蛋白潜在的抗原 HLA-A2 结合缺陷。
Front Immunol. 2022 Jan 18;12:764949. doi: 10.3389/fimmu.2021.764949. eCollection 2021.
6
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.鉴定 SARS-CoV-2 核衣壳和刺突 T 细胞表位以评估 T 细胞免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02002-20.
7
Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition.分析预测 SARS-CoV-2 变异对 CD8 T 细胞识别的影响有限。
Front Immunol. 2022 Apr 27;13:891524. doi: 10.3389/fimmu.2022.891524. eCollection 2022.
8
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 T Cells.氨基酸替换 HLA-B*27 限制性 T 细胞表位可预防乙型肝炎病毒特异性 CD8 T 细胞识别。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.01891-17. Print 2018 Jul 1.
9
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes.免疫原性表位突变免疫应答中高度同源T细胞受体库的特征
Int J Mol Sci. 2024 Nov 23;25(23):12591. doi: 10.3390/ijms252312591.
10
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.在 COVID-19 康复个体中鉴定的与 SARS-CoV-2 的奥密克戎变异株相关的突变和 CD8 T 细胞表位之间最小交叉。
mBio. 2022 Apr 26;13(2):e0361721. doi: 10.1128/mbio.03617-21. Epub 2022 Mar 1.

引用本文的文献

1
Emergence and transmission dynamics of the FY.4 Omicron variant in Kenya.肯尼亚FY.4奥密克戎变体的出现与传播动态
Virus Evol. 2025 May 11;11(1):veaf035. doi: 10.1093/ve/veaf035. eCollection 2025.
2
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.疫苗接种频率对COVID-19公共卫生结果的影响:基于模型的分析。
Vaccines (Basel). 2025 Mar 30;13(4):368. doi: 10.3390/vaccines13040368.
3
Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective multicenter study.

本文引用的文献

1
The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages.SARS-CoV-2 N501Y 谱系的出现和持续趋同进化。
Cell. 2021 Sep 30;184(20):5189-5200.e7. doi: 10.1016/j.cell.2021.09.003. Epub 2021 Sep 7.
2
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 T cell responses.SARS-CoV-2 突变在 MHC-I 限制性表位逃避 CD8 T 细胞反应。
Sci Immunol. 2021 Mar 4;6(57). doi: 10.1126/sciimmunol.abg6461.
3
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
使用监督式机器学习识别与重症新型冠状病毒肺炎相关的患者人口统计学、临床和严重急性呼吸综合征冠状病毒2基因组因素:一项回顾性多中心研究
BMC Infect Dis. 2025 Jan 28;25(1):132. doi: 10.1186/s12879-025-10450-3.
4
Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)表位免疫反应的综合分析:揭示疫苗开发的潜在靶点
Biology (Basel). 2025 Jan 14;14(1):67. doi: 10.3390/biology14010067.
5
Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines.下一代冠状病毒疫苗的抗原递送平台
Vaccines (Basel). 2024 Dec 31;13(1):30. doi: 10.3390/vaccines13010030.
6
Features of Highly Homologous T-Cell Receptor Repertoire in the Immune Response to Mutations in Immunogenic Epitopes.免疫原性表位突变免疫应答中高度同源T细胞受体库的特征
Int J Mol Sci. 2024 Nov 23;25(23):12591. doi: 10.3390/ijms252312591.
7
A phylogenetics and variant calling pipeline to support SARS-CoV-2 genomic epidemiology in the UK.一种支持英国新冠病毒基因组流行病学研究的系统发育学与变异体检测流程。
Virus Evol. 2024 Oct 17;10(1):veae083. doi: 10.1093/ve/veae083. eCollection 2024.
8
In-silico evaluation of the T-cell based immune response against SARS-CoV-2 omicron variants.基于 SARS-CoV-2 奥密克戎变异株的 T 细胞免疫反应的计算机模拟评估。
Sci Rep. 2024 Oct 25;14(1):25413. doi: 10.1038/s41598-024-75658-w.
9
The molecular mechanisms of CD8 T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions.TCR-pMHC 相互作用介导的 CD8 T 细胞对 SARS-CoV-2 感染的分子机制。
Front Immunol. 2024 Oct 10;15:1468456. doi: 10.3389/fimmu.2024.1468456. eCollection 2024.
10
Systematic analysis of SARS-CoV-2 Omicron subvariants' impact on B and T cell epitopes.奥密克戎变异株对 B 细胞和 T 细胞表位影响的系统分析。
PLoS One. 2024 Sep 19;19(9):e0307873. doi: 10.1371/journal.pone.0307873. eCollection 2024.
在 COVID-19 患者中,功能性 SARS-CoV-2 特异性 T 细胞的早期诱导与快速病毒清除和轻症疾病相关。
Cell Rep. 2021 Feb 9;34(6):108728. doi: 10.1016/j.celrep.2021.108728. Epub 2021 Jan 21.
4
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.恢复期 COVID-19 个体中的 SARS-CoV-2 特异性 CD8+ T 细胞应答。
J Clin Invest. 2021 Mar 1;131(5). doi: 10.1172/JCI145476.
5
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.SARS-CoV-2 特异性 T 细胞被快速扩增用于治疗,并针对膜蛋白的保守区域。
Blood. 2020 Dec 17;136(25):2905-2917. doi: 10.1182/blood.2020008488.
6
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.SARS-CoV-2 表位被广泛的人类 T 细胞受体识别。
Immunity. 2020 Dec 15;53(6):1245-1257.e5. doi: 10.1016/j.immuni.2020.11.004. Epub 2020 Nov 13.
7
Characterization of pre-existing and induced SARS-CoV-2-specific CD8 T cells.鉴定存在的和诱导的 SARS-CoV-2 特异性 CD8 T 细胞。
Nat Med. 2021 Jan;27(1):78-85. doi: 10.1038/s41591-020-01143-2. Epub 2020 Nov 12.
8
Unbiased Screens Show CD8 T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.非偏向性筛选表明 COVID-19 患者的 CD8 T 细胞识别 SARS-CoV-2 中的共享表位,这些表位主要位于 Spike 蛋白之外。
Immunity. 2020 Nov 17;53(5):1095-1107.e3. doi: 10.1016/j.immuni.2020.10.006. Epub 2020 Oct 20.
9
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.SARS-CoV-2 衍生肽定义了异源和 COVID-19 诱导的 T 细胞识别。
Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30.
10
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.